Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. - Van Der Meeren O; Hatherill M; Nduba V; Wilkinson RJ; Muyoyeta M; Van Brakel E; Ayles HM; Henostroza G; Thienemann F; Scriba TJ; Diacon A; Blatner GL; et al. (The New England journal of medicine, 2018)